This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Masui, T. Articles by Cohen, S. M. Search for Related Content PubMed PubMed Citation Articles by Masui, T. Articles by Cohen, S. M.

H-ras Mutations in Rat Urinary Bladder Carcinomas Induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide and Sodium Saccharin, Sodium Ascorbate, or Related Salts¹

Department of Pathology and Microbiology [T. M., A. M. M., T. L. M., T. O., E. M. G, S. M. C.] and the Eppley Institute for Research on Cancer and Allied Diseases [H. F., J. C. P., S. M. C.], University of Nebraska Medical Center, Omaha, Nebraska 68198-3135

Male F344 rats were fed 0.2% N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide for 6 weeks and then fed 3% or 5% sodium saccharin, 5% sodium ascorbate, 3.12% calcium saccharin, 1.34% sodium chloride, 5.2% calcium saccharin plus 1.34% sodium chloride, or basal diet alone for 72 weeks. Protein and DNA were extracted from 89 bladder tumors [87 transitional cell carcinomas (TCC), 1 papilloma, and 1 sarcoma] from 86 rats. p21 expression was examined by Western blotting using a monoclonal antibody against p21 (NCC-RAS-004). H-ras mutations in exons 1 and 2 were examined by direct sequencing of DNA amplified by polymerase chain reaction. Sequencing results demonstrated mutations at codon 61 (CAA to CGA in 15 TCCs; CAA to CTA in 2 TCCs), at codon 12 (GGA to TGG in 1 TCC), and at codon 13 (GGC to GTC in 3 TCCs). Mutations at codon 61 were confirmed by faster mobility of the p21 band in Western blots. The level of p21 expression varied among samples, but many TCCs appeared to express more p21 than controls. The overall incidence of H-ras mutations was 24.4% (21 of 86 rats). The type of chemical used for the promoting phase had essentially no effect on H-ras mutation, suggesting that the effects observed were related to FANFT administration. The frequency of H-ras mutation in each group was negatively related to the incidence of carcinoma (r = -0.85; P < 0.01). Two groups of tumors (with or without the mutated ras gene) were compared for tumor size (reflected by the bladder weight), histological grading, and the presence of invasion. The size of tumors with mutated ras was significantly smaller than those without mutated ras. There was no difference in the histological grading between the two groups. Although not statistically significant, histological invasion was more frequently observed in tumors with mutated ras (14.3%) than in tumors without mutation (3.1%).

¹ Supported by USPHS Grants CA32513 and CA36727 from the National Cancer Institute and by a grant from the International Life Sciences Institute-Nutrition Foundation.

² To whom all requests for reprints should be addressed, at Department of Pathology and Microbiology, University of Nebraska Medical Center, 600 South 42nd Street, Omaha, NE 68198-3135.

Received 1/11/91. Accepted 4/22/91.

This article has been cited by other articles:

				R.A. Crallan, N.T. Georgopoulos, and J. Southgate Experimental models of human bladder carcinogenesis Carcinogenesis, March 1, 2006; 27(3): 374 - 381. [Abstract] [Full Text] [PDF]

				T. Ota, M. Asamoto, H. Toriyama-Baba, F. Yamamoto, Y. Matsuoka, T. Ochiya, T. Sekiya, M. Terada, H. Akaza, and H. Tsuda Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis Carcinogenesis, July 1, 2000; 21(7): 1391 - 1396. [Abstract] [Full Text] [PDF]